- The era of prostate-specific membrane antigen for the diagnosis and treatment of prostate cancer: A novel horizon
-
Song B, Hong SK
- KMID: 2542242
- Investig Clin Urol.
- 2023 May;64(3):197-199.
- doi: 10.4111/icu.20230106
-
- CITED
-
- Close
- SHARE
-
- Close
- The future role of precision medicine in male sexual dysfunction
-
Park HJ
- KMID: 2542243
- Investig Clin Urol.
- 2023 May;64(3):200-201.
- doi: 10.4111/icu.20230114
-
- CITED
-
- Close
- SHARE
-
- Close
- Animal models of bone metastatic prostate cancer
-
Tae JH, Chang IH
- KMID: 2542245
- Investig Clin Urol.
- 2023 May;64(3):219-228.
- doi: 10.4111/icu.20230026
Metastatic disease is a main cause of mortality in prostate cancer and remains to be incurable despite emerging new treatment agents. Development of novel treatment agents are confined within the... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of constipation on acute urinary retention following transrectal prostate biopsy
-
Sahin C, Sinanoglu O, Karaca Y, Yuksel A, Kucuk EV, Sarica K, Erdogan E
- KMID: 2542250
- Investig Clin Urol.
- 2023 May;64(3):272-278.
- doi: 10.4111/icu.20230011
Purpose: To evaluate the possible effect of constipation on the acute urinary retention (AUR) after transrectal ultrasound-guided prostate biopsy (TRUS PB). Materials and Methods: A total of 1,167 patients with prostate-specific... -
- CITED
-
- Close
- SHARE
-
- Close
- Linguistic and clinical validation of the Turkish version of Acute Cystitis Symptom Score for the diagnosis and patient-reported outcome in acute uncomplicated cystitis
-
Arda E, Alidjanov J, Ates S, Çek M, Piatz A, Wagenlehner FM, Naber KG
- KMID: 2542251
- Investig Clin Urol.
- 2023 May;64(3):279-288.
- doi: 10.4111/icu.20230010
Purpose: The Acute Cystitis Symptom Score (ACSS) was developed as a self-reporting questionnaire for diagnosing and monitoring acute uncomplicated cystitis (AC) in female patients. The study aims at the translation... -
- CITED
-
- Close
- SHARE
-
- Close
- Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
-
Chung DY, Kang DH, Jung HD, Lee JY, Kim DK, Ha JS, Jeon J, Cho KS
- KMID: 2542247
- Investig Clin Urol.
- 2023 May;64(3):242-254.
- doi: 10.4111/icu.20230058
The oncologic outcomes of cytoreductive prostatectomy (CRP) in oligometastatic prostate cancer (OmPCa) are still controversial. Therefore, we conducted a systematic review and meta-analysis on the oncologic outcome of CRP in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study
-
Lim DG, Jung SI, Hwang EC, Kim TH, Bae S, Huh JS, Lee SJ, Chung H, Choi H
- KMID: 2542252
- Investig Clin Urol.
- 2023 May;64(3):289-295.
- doi: 10.4111/icu.20220413
Purpose: Recent studies have highlighted increasing infectious complications due to fluoroquinolone (FQ)-resistant organisms in men undergoing transrectal ultrasound-guided prostate biopsy (TRUSPB). This study investigated whether fosfomycin (FM)-based antibiotic prophylaxis reduces... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic responses to chemotherapy or immunotherapy by molecular subtype in bladder cancer patients: A meta-analysis and systematic review
-
Wang S, Yuan X, Shen Z, Zhao J, Zheng B, Zhang J, Ge C
- KMID: 2542246
- Investig Clin Urol.
- 2023 May;64(3):229-241.
- doi: 10.4111/icu.20230015
To systematically evaluate the differences in therapeutic response to chemotherapy or immunotherapy between different molecular subtypes of bladder cancer (BC). A comprehensive literature search was performed up to December 2021.... -
- CITED
-
- Close
- SHARE
-
- Close
- Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies
-
Kim KH, Lee HW, Ha HK, Seo HK
- KMID: 2542244
- Investig Clin Urol.
- 2023 May;64(3):202-218.
- doi: 10.4111/icu.20230006
Bladder cancer ranks as the 10th most common cancer type globally, and muscle-invasive disease accounts for approximately 25% of newly diagnosed bladder cancers. Despite definitive treatment, 50% of patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparing dusting and fragmenting efficiency using the new SuperPulsed thulium fiber laser versus a 120 W Holmium:YAG laser
-
Chew BH, Koo KC, Halawani A, Lundeen CJ, Knudsen BE, Molina WR
- KMID: 2542249
- Investig Clin Urol.
- 2023 May;64(3):265-271.
- doi: 10.4111/icu.20230071
Purpose: Holmium:YAG laser lithotripsy requires high amperage power and has an upper limit of frequency and a minimal fiber size. The technology utilizing thulium-doped fiber offers low pulse energy settings... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model
-
Choi J, Jung TY, Kim JH, Maeng S, Kang SJ, Kim M, Choi YW, Choi SY, Kim SH, Chang IH
- KMID: 2542253
- Investig Clin Urol.
- 2023 May;64(3):296-305.
- doi: 10.4111/icu.20220293
Purpose: We investigated the efficacy and optimal dosage of recombinant Bacillus Calmette-Guérin-dltA (rBCG-dltA) in a high-th roughput 3D bio-printed bladder cancer-on-a-chip (BCOC) and orthotopic bladder cancer mouse model. Materials and Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease
-
Shin JH, Kim YH, Lee MK, Min HS, Cho H, Kim H, Kim YC, Lee YS, Shin TY
- KMID: 2542248
- Investig Clin Urol.
- 2023 May;64(3):255-264.
- doi: 10.4111/icu.20220411
Purpose: Total kidney volume (TKV) measurement is crucial for selecting treatment candidates in autosomal dominant polycystic kidney disease (ADPKD). We developed and investigated the performance of fully-automated 3D-volumetry model and... -
- CITED
-
- Close
- SHARE
-
- Close
